Understanding the unmet needs in insomnia treatment: a systematic literature review of real-world evidence

References

• National Sleep Foundation. What is Insomnia? 2019. https://www.sleepfoundation.org/insomnia/what-insomnia. September 2020. Last accessed November 5, 2021.
   Google Scholar
• Ancoli-Israel EA. The impact and prevalence of chronic insomnia and other sleep disturbances associated with chronic illness. Am J Manage Care. 2006;12(Suppl(8):S221–S229.
   Web of Science ®Google Scholar
• Luyster F, Buysse D, Strollo P. Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research. J Clin Sleep Med. 2010;06(02):196–204.
   Google Scholar
• Ishak WW, Bagot K, Thomas S, et al. Quality of life in patients suffering from insomnia. Innov Clin Neurosci. 2012;9(10):13–26.
   PubMedGoogle Scholar
• Daley M, Morin CM, LeBlanc M, et al. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep. 2009;32(1):55–64.
   PubMed Web of Science ®Google Scholar
• Hägg SA, Torén K, Lindberg E. Role of sleep disturbances in occupational accidents among women. Scand J Work Environ Health. 2015;41(4):368–376.
   PubMed Web of Science ®Google Scholar
• Leger D, Bayon V, Ohayon MM, et al. Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries. J Sleep Res. 2014;23(2):143–152.
   PubMed Web of Science ®Google Scholar
• Rudisill TM, Zhao S, Abate MA, et al. Trends in drug use among drivers killed in U.S. traffic crashes, 1999–2010. Accid Anal Prev. 2014;70:178–187.
   PubMed Web of Science ®Google Scholar
• Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–1181.
   PubMed Web of Science ®Google Scholar
• Yu N-W, Chen P-J, Tsai H-J, et al. Association of benzodiazepine and Z-drug use with the risk of hospitalisation for fall-related injuries among older people: a nationwide nested case–control study in Taiwan. BMC Geriatr. 2017;17(1):140.
   Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Management of insomnia disorder in adults: current state of the evidence 2017. https://effectivehealthcare.ahrq.gov/products/insomnia/clinician.
   Google Scholar
• Jacob L, Rapp MA, Kostev K. Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis. Ther Adv Psychopharmacol. 2017;7(6–7):191–200.
   PubMed Web of Science ®Google Scholar
• Lai LL, Tan MH, Lai YC. Prevalence and factors associated with off-label antidepressant prescriptions for insomnia. Drug Healthc Patient Saf. 2011;3:27–36.
   PubMedGoogle Scholar
• Lie J, Tu K, Shen D, et al. Pharmacological treatment of insomnia. PT. 2015;40(11):759–768.
   PubMedGoogle Scholar
• Cochrane Training. Cochrane Handbook for Systematic Reviews of Interventions 2019. https://training.cochrane.org/handbook.
   Google Scholar
• riskofbias.info. ROBINS-I tool 2016. https://www.riskofbias.info/welcome/home/current-version-of-robins-i/robins-i-tool-2016.
   Google Scholar
• Asai Y, Sano H, Miyazaki M, et al. Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese drug-use results survey. Drugs Res Des. 2019;19(1):27–46.
   Google Scholar
• Azermai M, Elseviers M, Petrovic M, et al. Assessment of antipsychotic prescribing in Belgian nursing homes. Int Psychogeriatr. 2011;23(8):1240–1248.
   PubMed Web of Science ®Google Scholar
• Azermai M, Elseviers M, Petrovic M, et al. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol Clin Exp. 2011;26(1):12–20.
   PubMed Web of Science ®Google Scholar
• Bourgeois J, Elseviers MM, Van Bortel L, et al. The use of antidepressants in Belgian nursing homes: focus on indications and dosages in the PHEBE study. Drugs Aging. 2012;29(9):759–769.
   PubMed Web of Science ®Google Scholar
• Chow ES, Zangeneh-Kazemi A, Akintan O, et al. Prescribing practices of quetiapine for insomnia at a tertiary care inpatient child and adolescent psychiatry unit: a continuous quality improvement project. J Canad Acad Child Adolesc Psychiatry. 2017;26(2):98–103.
   PubMed Web of Science ®Google Scholar
• Deferio JJ, Levin TT, Cukor J, et al. Using electronic health records to characterize prescription patterns: focus on antidepressants in nonpsychiatric outpatient settings. JAMIA Open. 2018;1(2):233–245.
   PubMedGoogle Scholar
• Dobia A, Ryan K, Grant D, et al. Current clinical practice for using benzodiazepine and Z-drugs for managing primary insomnia in adults in a tertiary hospital in Saudi Arabia: an audit study. International journal of. Pharmacy Pract. 2019;7(1):15– 14.
   Web of Science ®Google Scholar
• Hatano M, Kamei H, Inagaki R, et al. Assessment of switching to suvorexant versus the use of add-on suvorexant in combination with benzodiazepine receptor agonists in insomnia patients: a retrospective study. Clin Psychopharmacol Neurosci. 2018;16(2):184–189.
   PubMed Web of Science ®Google Scholar
• Hussain A, Ibrahim MI, Malik M. Assessment of disease management of insomnia at community pharmacies through simulated visits in Pakistan. Pharm Pract. 2013;11(4):179–184.
   PubMedGoogle Scholar
• Kunz D, Bineau S, Maman K, et al. Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database. Expert Opin Pharmacother. 2012;13(1):9–16.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Sano H, Asai Y, et al. Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan. Curr Med Res Opin. 2020;36(3):465–471.
   PubMed Web of Science ®Google Scholar
• Kolla BP, Lovely JK, Mansukhani MP, Manukhani, et al. Zolpidem is independently associated with increased risk of inpatient falls. J Hosp Med. 2013;8(1):1–6.
   PubMed Web of Science ®Google Scholar
• Li CT, Bai YM, Lee YC, et al. High dosage of hypnotics predicts subsequent sleep-related breathing disorders and is associated with worse outcomes for depression. Sleep. 2014;37(4):803–809.
   PubMed Web of Science ®Google Scholar
• Dharni A, Coates D, Padencheri S. Psychotropic medication profile in youth mental health settings in Australia. Aust New Zeal J Psychiatry. 2018;52(1 Supplement 1):87.
   PubMed Web of Science ®Google Scholar
• Chen PL, Lee WJ, Sun WZ, et al. Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS One. 2012;7(11):e49113.
   PubMed Web of Science ®Google Scholar
• Chen TY, Lee S, Buxton OM. A greater extent of insomnia symptoms and Physician-Recommended sleep medication use predict fall risk in community-dwelling older adults. Sleep. 2017;40(11).
   Web of Science ®Google Scholar
• Chung KH, Li CY, Kuo SY, et al. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study. J Clin Sleep Med. 2015;11(5):543–551.
   PubMed Web of Science ®Google Scholar
• Drake CL, Vargas I, Roth T, et al. Quantitative measures of nocturnal insomnia symptoms predict greater deficits across multiple daytime impairment domains. Behav Sleep Med. 2015;13(1):73–87.
   PubMed Web of Science ®Google Scholar
• Lee J, Jung SJ, Choi JW, et al. Use of sedative-hypnotics and the risk of Alzheimer’s dementia: a retrospective cohort study. Plos One. 2018;13(9):e0204413.
   PubMed Web of Science ®Google Scholar
• Maeda T, Babazono A, Nishi T, et al. Quantification of adverse effects of regular use of triazolam on clinical outcomes for older people with insomnia: a retrospective cohort study. Int J Geriatr Psychiatry. 2016;31(2):186–194.
   PubMed Web of Science ®Google Scholar
• Manthey L, Lohbeck M, Giltay EJ, et al. Correlates of benzodiazepine dependence in the Netherlands study of depression and anxiety. Addiction. 2012;107(12):2173–2182.
   PubMed Web of Science ®Google Scholar
• Vijay A, Becker JE, Ross JS. Patterns and predictors of off-label prescription of psychiatric drugs. PLoS One. 2018;13(7):e0198363.
   PubMed Web of Science ®Google Scholar
• Redeker NS, Jeon S, Muench U, et al. Insomnia symptoms and daytime function in stable heart failure. Sleep. 2010;33(9):1210–1216.
   PubMed Web of Science ®Google Scholar
• Urru SAM, Pasina L, Minghetti P, et al. Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia. Int J Clin Pharm. 2015;37(6):1004–1008.
   PubMed Web of Science ®Google Scholar
• Bluestein D, Rutledge CM, Healey AC. Psychosocial correlates of insomnia severity in primary care. J Am Board Fam Med. 2010;23(2):204–211.
   PubMed Web of Science ®Google Scholar
• Coe HV, Hong IS. Safety of low doses of quetiapine when used for insomnia. Ann Pharmacother. 2012;46(5):718–722.
   PubMed Web of Science ®Google Scholar
• Glozier N, Moullaali TJ, Sivertsen B, et al. The course and impact of poststroke insomnia in stroke survivors aged 18 to 65 years: results from the psychosocial outcomes in StrokE (POISE) study. Cerebrovasc Dis Extra. 2017;7(1):9–20.
   PubMed Web of Science ®Google Scholar
• Lian Y, Xiao J, Liu Y, et al. Associations between insomnia, sleep duration and poor work ability. J Psychosom Res. 2015;78(1):45–51.
   PubMed Web of Science ®Google Scholar
• Santos-Silva R, Castro LS, Taddei JA, et al. Sleep disorders and demand for medical services: evidence from a population-based longitudinal study. PLoS One. 2012;7(2):e30085.
   PubMed Web of Science ®Google Scholar
• Suh S, Yang HC, Fairholme CP, et al. Who is at risk for having persistent insomnia symptoms? A longitudinal study in the general population in Korea. Sleep Med. 2014;15(2):180–186.
   PubMed Web of Science ®Google Scholar
• Vallieres A, Azaiez A, Moreau V, et al. Insomnia in shift work. Sleep Med. 2014;15(12):1440–1448.
   PubMed Web of Science ®Google Scholar
• Van Mill JG, Vogelzangs N, Hoogendijk WJG, et al. Sleep disturbances and reduced work functioning in depressive or anxiety disorders. Sleep Med. 2013;14(11):1170–1177.
   PubMed Web of Science ®Google Scholar
• Wilkerson AK, Sahlem GL, Bentzley BS, et al. Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program. J Subst Abuse Treat. 2019;104:97–103.
   PubMed Web of Science ®Google Scholar
• Aasvik J, Stiles TC, Woodhouse A, et al. The effect of insomnia on neuropsychological functioning in patients with comorbid symptoms of pain, fatigue, and mood disorders. Arch Clin Neuropsychol. 2018;33(1):14–23.
   PubMed Web of Science ®Google Scholar
• Amaral MOP, de Almeida Garrido AJ, de Figueiredo Pereira C, et al. Quality of life, sleepiness and depressive symptoms in adolescents with insomnia: a cross-sectional study. Atten Prim. 2017;49(1):35–41.
   PubMed Web of Science ®Google Scholar
• Bolge SC, Balkrishnan R, Kannan H, et al. Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause. 2010;17(1):80–86.
   PubMed Web of Science ®Google Scholar
• Combs D, Goodwin L, Quan SF, et al. Insomnia, health-related quality of life and health outcomes in children: a seven year longitudinal cohort. Sci Rep. 2016;6:27921.
   PubMed Web of Science ®Google Scholar
• Cross NE, Carrier J, Postuma RB, et al. Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian longitudinal study on aging. Sleep. 2019;42(8):zsz114.
   PubMed Web of Science ®Google Scholar
• Erickson EA, Stahlman S, McNellis MG. Insomnia and motor vehicle accident-related injuries, active component, U.S. Armed forces, 2007–2016. Defence Health Agency. 2017;24(12):2–11.
   Google Scholar
• Uchmanowicz I, Markiewicz K, Uchmanowicz B, et al. The relationship between sleep disturbances and quality of life in elderly patients with hypertension. CIA. 2019;14:155–165.
   Web of Science ®Google Scholar
• Lin CL, Chung CH, Tsai YH, et al. Association between sleep disorders and injury: a nationwide population-based retrospective cohort study. Inj Prev. 2016;22(5):342–346.
   PubMed Web of Science ®Google Scholar
• Sasai T, Inoue Y, Komada Y, et al. Effects of insomnia and sleep medication on health-related quality of life. Sleep Med. 2010;11(5):452–457.
   PubMed Web of Science ®Google Scholar
• Shekleton JA, Flynn-Evans EE, Miller B, et al. Neurobehavioral performance impairment in insomnia: relationships with self-reported sleep and daytime functioning. Sleep: J Sleep Sleep Disord Res. 2014;37(1):107–116.
   Google Scholar
• Blank M, Zhang J, Lamers F, et al. Health correlates of insomnia symptoms and comorbid mental disorders in a nationally representative sample of US adolescents. Sleep. 2015;38(2):197–204.
   PubMed Web of Science ®Google Scholar
• Schroeck JL, Ford J, Conway EL, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther. 2016;38(11):2340–2372.
   PubMed Web of Science ®Google Scholar
• Anderson LH, Whitebird RR, Schultz J, et al. Healthcare utilization and costs in persons with insomnia in a managed care population. Am J Manage Care. 2014;20(5):e157–e65.
   PubMed Web of Science ®Google Scholar
• Asche CV, Joish VN, Camacho F, et al. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder. Curr Med Res Opin. 2010;26(8):1843–1853.
   PubMed Web of Science ®Google Scholar
• Bolge SC, Joish VN, Balkrishnan R, et al. Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings among anxiety and depression sufferers: results of a national survey. Prim Care Comp J Clin Psychiatry. 2010;12(2):PCC.09m00824.
   Google Scholar
• Bolge SC, Joish VN, Balkrishnan R, et al. Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings. Popul Health Manage. 2010;13(1):15–20.
   PubMed Web of Science ®Google Scholar
• Espie CA, Pawlecki B, Waterfield D, et al. Insomnia symptoms and their association with workplace productivity: cross-sectional and pre–post intervention analyses from a large multinational manufacturing company. Sleep Health. 2018;4(3):307–312.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund PA, Coulouvrat C, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep: J Sleep Sleep Disord Res. 2011;34(9):1161–1171.
   Google Scholar
• Sarsour K, Kalsekar A, Swindle R, et al. The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep. 2011;34(4):443–450.
   PubMed Web of Science ®Google Scholar
• Scott GW, Scott HM, O’Keeffe KM, et al. Insomnia – treatment pathways, costs and quality of life. Cost Eff Resour Alloc. 2011;9:10.
   PubMedGoogle Scholar
• Sivertsen B, Bjornsdottir E, Overland S, et al. The joint contribution of insomnia and obstructive sleep apnoea on sickness absence. J Sleep Res. 2013;22(2):223–230.
   PubMed Web of Science ®Google Scholar
• Sivertsen B, Overland S, Bjorvatn B, et al. Does insomnia predict sick leave? The Hordaland Health Study. J Psychosom Res. 2009;66(1):67–74.
   PubMed Web of Science ®Google Scholar
• Kitazawa M, Yoshimura M, Kuo-Ching L, et al. Differences of sleep in healthy subjects and patients with mood disorders in remission. Sleep Biol Rhythms. 2018;16(4):493.
   Google Scholar
• Doghramji K, Tanielian M, Certa K, et al. Insomnia severity, prevalence, predictors and rate of identification in a sample of hospitalized psychiatric patients. Sleep. 2018:41(S1):A161.
   Google Scholar
• Nadeau S, Vallieres A, Leanza Y. Patient’s perception of comorbid anxiety and insomnia: a qualitative approach. ESRS 2018;P432:289.
   Google Scholar
• Ju G, Jung S. The effect of sleep disturbance and resilience on suicidal idea. WSC 2017;#008:156.
   Google Scholar
• Haghighi A, Athey A, Killgore W, et al. Insufficient sleep duration and insomnia symptoms independently predict suicide ideation in student athletes and non-athletes. Sleep. 2018;41(S1):A363–A363.
   Google Scholar
• Komada Y, Nomura T, Okajima I, et al. The course of insomnia and health related quality of life over two years: a longitudinal study in the general population in Japan. Sleep Biol Rhythms. 2011;9(4):258.
   Google Scholar
• Sharma S, Parekh K, Beria J, et al. Incidence of depression in patients with sleep disorders and its impact on their quality of life. 2018:41;A367.
   Google Scholar
• Morlock A, Dobrescu R. Self-reported insomnia symptoms and health related quality of life in the us adult population. ISPOR. 2018;21(S1):PND41.
   Google Scholar
• Ortega-Robles D, Olivera-Lopez C, Jimenez-Genchi A. Neuropsychological performance in insomnia with short sleep duration comorbid with major depressive disorder. Sleep. 2019;42:A359.
   Google Scholar
• Schlarb A, Grunwald J. Insomnia, nightmares and daytime sleepiness in university students with ADHD. ESRS 2018;P463:304.
   Google Scholar
• Talwalkar P, Patel I, Farishta F, et al. Prevalence and clinico-epidemiology of insomnia in Indian patients with type 2 diabetes mellitus. Sleep Med. 2017;40(Supplement 1):e6.
   Web of Science ®Google Scholar
• Fernandez-Mendoza F, He F, Vgnotzas A, et al. Insomnia with objective short sleep duration is associated with cognitive impairment: a closer look at cardiometabolic brain health. Sleep. 2019;42(Suppl 1):A145–A145.
   Google Scholar
• Philip R, Catcheside P, Stevens D, et al. Comorbid insomnia and sleep apnoea is associated with greater neurocognitive impairment compared with OSA alone. WSC 2017;#014:174.
   Google Scholar
• Dubrovsky B, Weingarten JA, Cunningham J, et al. Depressive symptoms account for self reported sleep quality and insomnia severity in obstructive sleep apnea patients. Sleep. 2019;42(Supplement_1):A233–A233.
   Google Scholar
• Poradowska E, Slusarz A, Wierzbicka A, et al. Chronotype and psychiatric comorbidity in patients with insomnia referred to sleep disorders center. ESRS. 2018;P706:410.
   Google Scholar
• Kulkarni AS. Depressive symptomatology, medication persistence, and associated health care costs in older adults with insomnia; 2011.
   Google Scholar
• Choi J, Lee J, Jung S, et al. Use of sedative-hypnotics and mortality: a population-based retrospective cohort study. Sleep. 2017;40:A127.
   Google Scholar
• Bang YR, Jeon HJ, Yoon YI. Effects of benzodiazepine use in chronic insomnia on cognitive function and EEG. WSC 2019;#118:356.
   Google Scholar
• Tang C, Chang W, Lee H. Safety of zolpidem and zopiclone during pregnancy: a nationwide retrospective cohort study of risks of preterm delivery and low birth weight at birth and intellectual disability during 7-year follow-up. WSC 2019;#225:711.
   Google Scholar
• Pigeon W, Kane C, Bishop T, et al. Suicide attempts in the 12 months following incident prescriptions of sedative–hypnotic medications in a large healthcare system. Sleep. 2017;40(suppl_1):A129–A129.
   Web of Science ®Google Scholar
• Erik Laugsand L, Strand LB, Vatten LJ, et al. Insomnia symptoms and risk for unintentional fatal injuries: the HUNT study. Sleep. 2014;37(11):1777–186C.
   PubMed Web of Science ®Google Scholar
• Richardson K, Loke Y, Savva GM, et al. Unintended effects of Z-drugs (zolpidem, zopiclone and zaleplon) in people living with dementia. Alzheimer’s Demen. 2018;14(7 Supplement):P1622.
   Google Scholar
• Tang R, Athey A, Killgore W, et al. Drowsy driving in student athletes: impact of insomnia sleepiness, and mood. Sleep. 2018;41(suppl_1):A73–A73.
   Web of Science ®Google Scholar
• Morin C, Ivers H, Altena E, et al. Insomnia and risk of traffic accidents: a 5-year follow up cohort study. J Sleep Res. 2016;25(Supplement 1):305.
   Google Scholar
• Contreras Rey MB, Sanchez Gomez E, Yanez Feria D, et al. Analysis of the utilisation of zolpidem in hospitalised patients. Eur J Hosp Pharm. 2016;23(Suppl 1):A224.3–A5.
   Google Scholar
• El Gewely M, Dusablon C, Montplaisir JY, et al. The off-label use of antipsychotics for insomnia disorder: a major public health concern. Sleep Med. 2019;64(Supplement 1):S103.
   Google Scholar
• Hellwig H, Lugo A. Evaluation of quetiapine for primary insomnia in active duty members in the national capital area. J Am Pharm Assoc. 2012;52(2):237–238.
   Google Scholar
• Mains AL, Moeller KE, King AR. Prescribing prevalence of low-dose quetiapine in a large academic medical center. Pharmacotherapy. 2010;30(10):467e.
   Google Scholar
• Pagan-Ferrer J, Hagiwara Y, Lockman K. Sleepless nights: trazodone use and insomnia evaluation in the palliative care clinic (QI728). J Pain Symptom Manage. 2019;57(2):470–471.
   Web of Science ®Google Scholar
• Roth T, Cooke D, Singh NN. Treatment of middle-of-the-night insomnia: current medical practice. Sleep Med. 2011;12:S66.
   Google Scholar
• Wallace LE, Kadakia A. Pediatric insomnia and utilization of prescription sedative-hypnotics: a descriptive study. Pharmacoepidemiol Drug Saf. 2012;21:144.
   Web of Science ®Google Scholar
• Wong J, Kurteva S, Tamblyn R. Does nonadherence with antidepressants differ by treatment indication? Pharmacoepidemiol Drug Saf. 2019;28(Supplement 2):427.
   Google Scholar
• Wong J, Toh D. Trends in prescribing and dispensing of common insomnia drugs as compared to national guideline recommendations. Pharmacoepidemiol Drug Saf. 2019;28(Supplement 2):272.
   Google Scholar
• Lee M, Jung S, Choi J, et al. Trends in prescriptions of sedative hypnotics among Korean adults: a nationwide prescription database study 2011–2015. Sleep. 2017;40(suppl_1):A128–A128.
   Web of Science ®Google Scholar
• Alfurayh I, Nadkarni P. Good night’s sleep: an audit to study antipsychotic prescriptions for insomnia in the mentally ill. American Psychiatric Association Annual Meeting 2018.
   Google Scholar
• Hossny E, Bodic MM, Jacob T, et al. My patient can’t sleep: management of insomnia on an inpatient psychiatric unit. American Psychiatric Association Annual Meeting 2017.
   Google Scholar
• Cheung J, Jarrin D, Beaulieu-Bonneau S, et al. Trajectories of use of over-the-counter and natural products for sleep: a five-year follow-up. World Sleep Congr. 2017.
   Google Scholar
• Practices TAfBB. Benzodiazepines, z-drugs, and medical decision-making. https://benzoreform.org/resources-for-prescribers/#offlabeluses.
   Google Scholar
• Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159.
   PubMedGoogle Scholar
• Cramer J, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47.
   PubMed Web of Science ®Google Scholar
• Lee K, Jeong J. Discontinuation rate of doxepin in insomnia patients. APA 2019;No. 182:100.
   Google Scholar
• Hong SC, Kim SM, editor. The compliances of doxepin for the treatment of insomnia in real world. ESRS 2018;P157:162.
   Google Scholar
• U.S Food and Drug Administration. FDA requiring labeling changes for benzodiazepines 2020. https://www.fda.gov/news-events/press-announcements/fda-requiring-labeling-changes-benzodiazepines.
   Google Scholar
• Electronic medicines compendium. Diazepam injection BP: EMC 2020. https://www.medicines.org.uk/emc/product/6274/smpc#gref.
   Google Scholar
• Kadotani H, Takami M, Nishikawa K, et al. Insomnia is associated with presenteeism in Japanese city government employees. Sleep. 2018;41(suppl_1):A136–A136.
   Web of Science ®Google Scholar
• Morlock A. DR. Self-reported insomnia symptoms and health related quality of life in the us adult population. Int Soc Pharmacoecon Outcomes Res. 2018.
   Google Scholar
• Morlock A, Dobrescu R. Characteristics of us adults with self-reported insomnia by insomnia symptoms – 2018 national sleep survey. International Society for Pharmacoeconomics and Outcomes Research 2019.
   Google Scholar
• Yang R, Hale L, Branas C, et al. Work productivity loss associated with sleep duration, insomnia severity, sleepiness, and snoring. Sleep. 2018;41(suppl_1):A74–A74.
   Web of Science ®Google Scholar
• U.S Department of health and human services. What is the U.S Opioid Epidemic 2020. https://www.hhs.gov/opioids/about-the-epidemic/index.html.
   Google Scholar